Iberdrola, S.A.:企業のM&A・事業提携・投資動向

◆英語タイトル:Iberdrola, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2153
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:165
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:電力
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Iberdrola, S.A. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Iberdrola, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Iberdrola, S.A. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Iberdrola, S.A.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Iberdrola, S.A.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Iberdrola, S.A.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Iberdrola, S.A. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Iberdrola, S.A.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Iberdrola, S.A.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Deal reports 8
CORPORATE VENTURING 32
Corporate Venturing – Overview 32
Corporate Venturing – Deal reports 33
PARTNERSHIP 39
Partnership – Deal reports 39
CAPITAL RAISING 53
Capital Raising – Deal reports 53
DIVESTMENTS 66
Divestments – Overview 66
Divestments – Deal reports 67
PRIVATE EQUITY & OWNERSHIP 131
Private Equity and Ownership – Deal reports 131
APPENDIX 155
Contact Us 155
About MarketLine Financial Deals Database 155
Deal Definition and Methodology 157
About MarketLine 164

List of Tables
Table 1: Iberdrola corporate venturing volume and value trend (2014-YTD2018)
Table 2: Iberdrola corporate venturing by geography (2014-YTD2018)
Table 3: Iberdrola divestments volume and value trend (2014-YTD2018)
Table 4: Iberdrola divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Iberdrola corporate venturing volume and value trend (2014-YTD2018)
Figure 2: Iberdrola corporate venturing by geography (2014-YTD2018)
Figure 3: Iberdrola divestments volume and value trend (2014-YTD2018)
Figure 4: Iberdrola divestments by geography (2014-YTD2018)

★海外企業調査レポート[Iberdrola, S.A.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BASF SE (BAS)-石油・ガス分野:企業M&A・提携分析
    Summary BASF SE (BASF) is a chemical company, which carries out research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additives, e …
  • A.P. Moller – Maersk AS (MAERSK B)-石油・ガス分野:企業M&A・提携分析
    Summary A.P. Moller - Maersk A/S (APM) is a business conglomerate that carries out operations in global trade, shipping and energy. It operates through a network of tankers, supply ships, container vessels, car carriers, drilling rigs and special vessels. The company also carries out container termi …
  • Eastman Kodak Company:戦略・SWOT・企業財務分析
    Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report Summary Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bajaj Corp Limited:企業の戦略・SWOT・財務分析
    Bajaj Corp Limited - Strategy, SWOT and Corporate Finance Report Summary Bajaj Corp Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Immunovia AB (IMMNOV):企業の製品パイプライン分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • ESSA Pharma Inc (EPI):製薬・医療:M&Aディール及び事業提携情報
    Summary Essa Pharma Inc (Essa Pharma) is a drug developer that offers oncology therapeutics. The company develops EPI-506, disrupts androgen receptor transcriptional activity through selectively blocking the N-terminal domain of the AR. It also conducts research on prostate cancer and the androgen r …
  • Siemens Gamesa Renewable Energy SA (SGRE):企業の財務・戦略的SWOT分析
    Siemens Gamesa Renewable Energy SA (SGRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Lloyds Banking Group Plc:戦略・SWOT・企業財務分析
    Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report Summary Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Hillenbrand Inc (HI):企業の財務・戦略的SWOT分析
    Hillenbrand Inc (HI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Martin Midstream Partners LP (MMLP):企業の財務・戦略的SWOT分析
    Martin Midstream Partners LP (MMLP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Daiichi Sankyo Co Ltd (4568):企業の財務・戦略的SWOT分析
    Daiichi Sankyo Co Ltd (4568) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Occidental Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Occidental Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Occidental Petroleum Corp (Occidental) is an oil and gas exploration and production company with integrated assets. The company is active in upstream exploration and production; midstream a …
  • JGC Holdings Corp (1963)
    JGC Holdings Corp (1963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • New Jersey Resources Corp (NJR):企業の財務・戦略的SWOT分析
    New Jersey Resources Corp (NJR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • AstraZeneca UK Ltd-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca UK Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc is a provider of asthma treatment solutions. The company offers research and develops various novel and targeted medicines. It offers its medicines in therapeutic areas which include cardiovascular; oncology, respiratory, infl …
  • SuccessFactors, Inc.:企業の戦略的SWOT分析
    SuccessFactors, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Volkswagen Financial Services AG:企業の戦略・SWOT・財務情報
    Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Opsona Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Opsona Therapeutics Ltd (Opsona) is a drug developing company that conducts research, develops and commercializes new treatment for the autoimmune and inflammatory diseases and cancers. The company's OPN-305 is a humanized antibody used to reduce pro-inflammatory cytokine production that is …
  • UniFirst Corp (UNF):企業の財務・戦略的SWOT分析
    UniFirst Corp (UNF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Alkem Laboratories Ltd (ALKEM):製薬・医療:M&Aディール及び事業提携情報
    Summary Alkem Laboratories Ltd (Alkem) is a pharmaceutical company that develops, manufactures and markets generic and specialty pharmaceutical products. The company’s products include active pharmaceutical ingredients, generic products, branded products and nutraceuticals. Alkem provides drugs for …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆